QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 applied-dna-sciences-says-on-sept-30-announced-restructuring-plan-restructuring-plan-includes-60-workforce-reduction-estimates-14m-pre-tax-charges-for-reduction-in-q1-2026

On September 30, 2025, the Board of Directors of Applied DNA Sciences, Inc. (the "Company") authorized, and its officer...

 applied-dna-sciences-to-change-nasdaq-ticker-to-bnbx-on-october-7

Ticker changing from ‘APDN' to ‘BNBX' effective October 7, 2025Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied D...

Core News & Articles

Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's...

 applied-dna-announces-judy-murrah-has-voluntarily-resigned-from-her-role-of-president-and-ceo-will-remain-the-chairperson-of-the-board-until-a-replacement-is-nominated-and-appointed-clay-shorrock-as-president-and-chief-executive-officer-effective-immediately

Company LeadershipThe Company also announced today that Judy Murrah has voluntarily resigned from her role of President and CEO...

 applied-dna-58m-pipe-offerings-involves-4730178-shares-of-common-stock-and-common-warrants-a-cryptocurrency-offering-involving-3334471-prefunded-warrants-and-common-warrants-the-warrants-in-both-offerings-have-an-exercise-price-of-382-and-a-5-year-term

Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Compan

 applied-dna-sciences-secures-up-to-58m-pipe-to-initiate-bnb-focused-digital-asset-strategy-intends-to-change-ticker-to-bnbx

Appoints TradFi and DeFi Leaders as Advisers, Including Anthony ScaramucciEnhanced Staking and Yield Strategy Focused on BNB Na...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

 applied-dna-sciences-q3-eps-3341-beats-3750-estimate-sales-304393k-miss-1276m-estimate

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(33.41) per share which beat the analyst consensus estimate of...

 linearxdna-posts-on-x-linearx-is-appearing-at-the-5th-annual-mrna-based-therapeutics-summit-july-21---23-booth-16-were-thrilled-to-unveil-our-latest-innovation-the-linearx-ivt-discovery-kit--direct-access-to-our-advanced-solutions-for-rapid-high-efficiency-mrna-production

https://x.com/LineaRxDNA/status/1945840253995975135

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION